REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>

Hikma PharmaceuticalsAnnouncement

07/12/2016 09:40

RNS Number : 1937R
Hikma Pharmaceuticals Plc
07 December 2016
Notification and public disclosure of transactions by persons discharging managerial responsibilities
The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the purchase by Darhold Limited of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Chairman and Chief Executive, Vice Chairman and a Non-executive Director are directors of and shareholders in Darhold Limited. This announcement is made in accordance with article 19.3 of MAR.
Said Darwazah
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Said Darwazah
2
Reason for the notification
a)
Position/status
Chairman and Chief Executive Officer / PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Acquisition by Darhold Limited of 150,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Chairman and Chief Executive is a director of and shareholder in Darhold Limited with an equity interest of 21.67%.
c)
Price(s) and volume(s)
Price(s): 16.74
Volume(s): 50,000
Price(s): 16.82
Volume(s): 100,000
d)
Aggregated information
Aggregated volume: 150,000
Price: 16.79
e)
Date of the transaction
5 December and 6 December 2016
f)
Place of the transaction
London Stock Exchange (XLON)
Mazen Darwazah
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mazen Darwazah
2
Reason for the notification
a)
Position/status
Executive Vice Chairman / PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Acquisition by Darhold Limited of 10,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.92%.
c)
Price(s) and volume(s)
Price(s): 16.74
Volume(s): 50,000
Price(s): 16.82
Volume(s): 100,000
d)
Aggregated information
Aggregated volume: 150,000
Price: 16.79
e)
Date of the transaction
5 December and 6 December 2016
f)
Place of the transaction
London Stock Exchange (XLON)
Mohammed 'Ali' Al-Husry
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mohammed 'Ali' Al-Husry
2
Reason for the notification
a)
Position/status
Non-executive Director/ PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Acquisition by Darhold Limited of 10,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.01% through DKYB Limited, a vehicle owned by his family.
c)
Price(s) and volume(s)
Price(s): 16.74
Volume(s): 50,000
Price(s): 16.82
Volume(s): 100,000
d)
Aggregated information
Aggregated volume: 150,000
Price: 16.79
e)
Date of the transaction
5 December and 6 December 2016
f)
Place of the transaction
London Stock Exchange (XLON)
Peter Speirs, Company Secretary, Responsible for releasing this announcement
7 December 2016

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHGCBDDDXGBGLR